Single pill treatment in daily practice is associated with improved clinical outcomes and all-cause mortality in cardiovascular diseases: results from the START project

Weisser B, Wilke T, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, Maywald U, Randerath O, Mevius A, Boehm M (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

European Heart Journal Oxford University Press

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Pages Range: 2254-2254

Conference Proceedings Title: EUROPEAN HEART JOURNAL

DOI: 10.1093/eurheartj/ehac544.2254

Authors with CRIS profile

Roland Schmieder Professur für Innere Medizin (Nephrologie)

Involved external institutions

APONTIS PHARMA GmbH & Co. KG DE Germany (DE) Institut für Pharmakoökonomie und Arzneimittellogistik e.V. (IPAM) DE Germany (DE) Herz-Jesu-Krankenhaus Hiltrup DE Germany (DE) Universität des Saarlandes (UdS) DE Germany (DE) Deutsche Sporthochschule Köln DE Germany (DE) Christian-Albrechts-Universität zu Kiel DE Germany (DE) AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen DE Germany (DE)

How to cite

APA:

Weisser, B., Wilke, T., Predel, H.G., Schmieder, R., Wassmann, S., Gillessen, A.,... Boehm, M. (2022). Single pill treatment in daily practice is associated with improved clinical outcomes and all-cause mortality in cardiovascular diseases: results from the START project. In EUROPEAN HEART JOURNAL (pp. 2254-2254). OXFORD: OXFORD UNIV PRESS.

MLA:

Weisser, B., et al. "Single pill treatment in daily practice is associated with improved clinical outcomes and all-cause mortality in cardiovascular diseases: results from the START project." Proceedings of the EUROPEAN HEART JOURNAL OXFORD: OXFORD UNIV PRESS, 2022. 2254-2254.

BibTeX: Download